The Trump administration has asked a court to dismiss a lawsuit restricting access to the abortion pill mifepristone.
This decision is unexpected, considering President Trump's strong anti-abortion stance and past actions.
The lawsuit challenges FDA decisions that broadened mifepristone's availability, impacting abortion rights significantly.
The administration's legal argument centers on the lawsuit's location rather than the merits of the case itself.
